Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

92.00p
   
  • Change Today:
      1.40p
  • 52 Week High: 92.55p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 966.40m
  • Volume: 4,763,111
  • Market Cap: £889.09m
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £7,245,000
Giles Wilson 230,193 £211,778
Robyn Perriss 94,328 £86,782
Andrew Harrison 76,594 £70,466
Lynne Weedall 40,054 £36,850
Ian Rogers 20,270 £18,648
Ije Nwokori 6,559 £6,034

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £340,347,045
IngreGrsy Limited 369,942,440 £340,347,045
Permira Holdings Limited 364,142,440 £335,011,045
Artemis Investment Management LLP 86,997,521 £80,037,719
Fidelity Management & Research 32,500,000 £29,900,000
Intertrust Employee Benefit Trustee Limited 135,000 £124,200

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 92.00p
Change Today 1.40p
% Change 1.55 %
52 Week High 92.55p
52 Week Low 47.52p
Volume 4,763,111
Shares Issued 966.40m
Market Cap £889.09m
Beta 0.01

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 12-Sep-2025

Time Volume / Share Price
08:57 1,000,000 @ 89.85p
16:35 350,613 @ 92.00p
16:35 353 @ 92.00p
16:35 603 @ 92.00p
16:35 1,984 @ 92.00p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page